NAD/NADP Index Test

Your body runs on two closely related molecules that split the labor of keeping you alive. One, called NAD (nicotinamide adenine dinucleotide), drives energy production. The other, NADP (nicotinamide adenine dinucleotide phosphate), powers your cells' built-in defense and repair systems. The NAD/NADP Index captures the ratio between them, offering a snapshot of how your cellular machinery allocates its resources between generating fuel and protecting itself from wear and tear.

This is a newer, research-stage measurement. No major clinical guidelines currently recommend it, and standardized interpretation thresholds do not yet exist. But the underlying biology is well established and increasingly linked to aging, metabolic health, and disease risk. Getting a baseline now gives you personal data to track as the science matures.

What This Ratio Actually Tells You

NAD and NADP are both built from vitamin B3 (niacin). NADP is simply NAD with one extra chemical tag (a phosphate group) attached. Despite their nearly identical structures, they do very different jobs inside your cells.

NAD works on the energy side. When you eat food, your cells break it down through a chain of chemical reactions that generate a molecule called ATP, your body's universal energy currency. NAD is essential at almost every step of that chain. The NAD/NADP Index reflects how much of your total pool is committed to this energy-generating role versus the protective role described next.

NADP works on the defense side. Its active form, NADPH, fuels the recycling of your cells' main internal antioxidant (glutathione) and supplies the chemical energy needed to build fats, cholesterol, and the raw materials for DNA. When NADP levels are adequate relative to NAD, your cells have enough resources allocated to damage control and rebuilding.

The ratio between NAD and NADP is not a static number. It shifts in response to how much energy your cells need, how much damage they are dealing with, and how efficiently your body recycles these molecules. A ratio that drifts too far in either direction can signal that one system is being starved to feed the other.

The Link to Aging

NAD levels decline with age across virtually every tissue that has been studied, including skin, muscle, liver, and fat. A study measuring NAD in human skin found a strong negative relationship with age in both men and women. Plasma measurements in people aged 20 to 87 showed that the active form of NAD drops with age while its spent form (NADH) rises, suggesting cells gradually lose their ability to keep NAD in its working state.

This decline is driven by two forces. First, enzymes that consume NAD become more active as you age. One of these, called CD38, ramps up with chronic low-grade inflammation, chewing through NAD faster than your body can replace it. Second, the recycling enzyme your cells rely on most heavily to regenerate NAD (called NAMPT) becomes less active over time, especially in muscle and fat tissue.

Whether the NAD/NADP Index itself tracks this age-related decline in a predictable, clinically useful way has not been directly established. The individual components (NAD+ and NADP+) do change with age, but how their ratio behaves across a large aging population has not been the subject of dedicated longitudinal research. This is an area where your own serial data could prove more informative than any population average.

Metabolic Health Associations

The strongest population-level data connecting NAD to metabolic disease comes from a community study of 1,394 adults in China (average age 43). This study measured whole-blood NAD (not the NAD/NADP ratio specifically) and found a surprising pattern: people in the highest NAD group were roughly three times as likely to have metabolic disease as those in the lowest group. The association grew stronger with more metabolic problems present, reaching about four times the odds in people with three or more components (such as high blood pressure, abnormal blood sugar, or obesity together).

This counterintuitive finding, where higher NAD was linked to more disease rather than less, likely reflects a compensatory response. When cells are under metabolic stress, the body may ramp up NAD production as a defense mechanism, much like a fever signals an immune system fighting infection rather than causing the illness. The researchers noted that this cross-sectional snapshot cannot tell us whether elevated NAD preceded the disease or arose in response to it.

Separately, research in identical twins who differed in body weight found that obesity was linked to reduced activity of NAD-related genes in fat tissue, along with greater insulin resistance and inflammation. This suggests that in fat tissue specifically, NAD pathways become suppressed as metabolic health worsens.

Heart and Brain Connections

NAD depletion has been linked to several cardiovascular problems, including heart failure, high blood pressure, and damage to the lining of blood vessels. When heart muscle or brain tissue loses blood supply (as during a heart attack or stroke), a DNA repair enzyme called PARP-1 goes into overdrive, consuming enormous amounts of NAD in the process. This NAD crash contributes to cell death in the affected tissue.

A study measuring blood NAD in patients with various conditions found significantly lower levels in people with heart failure (averaging 13 micromolar) compared to healthy controls (18 micromolar). Patients with nerve-damaging neurological diseases also showed reduced levels (14 micromolar). These findings come from whole-blood NAD measurements, not the NAD/NADP ratio specifically, so they offer context about the broader NAD system rather than direct evidence about this particular index.

Kidney Function and NAD

Your kidneys play an underappreciated role in NAD biology. In chronic kidney disease, both NAD and NADH levels in kidney tissue decline, and several key enzymes in the NAD-building pathway become significantly less active. Acute kidney injury impairs the pathway your body uses to build NAD from scratch (called de novo synthesis), making kidney health an important variable when interpreting any NAD-related measurement.

Because kidney function directly affects how your body produces and clears NAD-related molecules, your kidney health should be considered alongside any NAD/NADP Index result. A declining trend in this index could reflect worsening kidney function rather than a systemic NAD problem, making companion kidney markers especially useful.

Tracking Your Trend

For a measurement this early in its clinical development, serial tracking is far more valuable than any single reading. One result tells you almost nothing. A trend across three or four readings, drawn at the same lab and under similar conditions, starts to tell a story.

There is reason to believe your personal baseline is relatively stable over time. One study documented long-term stability of individual NAD levels over 100 days, suggesting that meaningful shifts in your number are more likely to reflect real biological change than random noise. That said, precise data on how much the NAD/NADP Index fluctuates from day to day within the same person (the intra-individual coefficient of variation) has not been published.

A practical approach: get a baseline, retest in three to six months (especially if you are making dietary changes, starting a supplement, or beginning a new exercise program), then retest at least annually. If you are supplementing with an NAD precursor like nicotinamide riboside (NR) or nicotinamide mononucleotide (NMN), keep in mind that most supplementation studies have measured whole-blood NAD+ rather than the NAD/NADP ratio specifically. Your index may or may not move in the same direction as whole-blood NAD+ in response to supplementation, so track your actual results rather than assuming they will mirror published trial data.

When Results Can Be Misleading

A major challenge with NAD-related measurements is that different lab techniques can produce very different numbers from the same sample. A 2023 meta-analysis of published NAD and NADP measurements across mammalian tissues found significant variability both within and between methods. If you switch labs or your lab changes its assay, your numbers may shift for purely technical reasons.

Acute illness can distort your results. In hospitalized COVID-19 patients, NAD turnover was substantially increased, with the body simultaneously ramping up both NAD production and NAD consumption. Circulating NAD+ also showed an inverse relationship with C-reactive protein (a marker of inflammation), meaning any active infection or inflammatory episode could temporarily lower your reading.

Recent intense exercise can transiently boost NAD+ levels in blood immune cells. Both high-intensity intervals and moderate continuous exercise increased NAD+ in immune cells, so a blood draw shortly after a hard workout might not reflect your resting baseline. One reassuring finding: blood NAD and NADP concentrations do not appear to fluctuate with time of day, so you do not need to worry about scheduling your draw at a specific hour.

Kidney function is a less obvious confounder. Because the kidneys are active participants in NAD production and clearance, impaired kidney function can alter your NAD/NADP Index independently of what is happening in the rest of your body. If your kidney markers are abnormal, interpret this index with extra caution.